Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial. (2022)
Attributed to:
A genetically modified nasopharyngeal commensal as a platform for human bacteriotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2666-5247(22)00283-x
PubMed Identifier: 36462524
Publication URI: http://europepmc.org/abstract/MED/36462524
Type: Journal Article/Review
Volume: 3
Parent Publication: The Lancet. Microbe
Issue: 12
ISSN: 2666-5247